Mimedx (MDXG) Gross Profit (2016 - 2026)
Mimedx's Gross Profit history spans 16 years, with the latest figure at $41.6 million for Q1 2026.
- On a quarterly basis, Gross Profit fell 41.91% to $41.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $315.6 million, a 9.3% increase, with the full-year FY2025 number at $345.6 million, up 19.67% from a year prior.
- Gross Profit hit $41.6 million in Q1 2026 for Mimedx, down from $99.0 million in the prior quarter.
- Over the last five years, Gross Profit for MDXG hit a ceiling of $99.0 million in Q4 2025 and a floor of $41.6 million in Q1 2026.
- Historically, Gross Profit has averaged $68.4 million across 5 years, with a median of $68.7 million in 2024.
- Biggest five-year swings in Gross Profit: surged 38.22% in 2025 and later crashed 41.91% in 2026.
- Tracing MDXG's Gross Profit over 5 years: stood at $60.0 million in 2022, then increased by 21.64% to $73.0 million in 2023, then rose by 4.12% to $76.0 million in 2024, then skyrocketed by 30.32% to $99.0 million in 2025, then tumbled by 57.97% to $41.6 million in 2026.
- Business Quant data shows Gross Profit for MDXG at $41.6 million in Q1 2026, $99.0 million in Q4 2025, and $95.0 million in Q3 2025.